GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Family Office of America Inc (OTCPK:FOFA) » Definitions » Valuation Rank

FOFA (Family Office of America) Valuation Rank


View and export this data going back to 2006. Start your Free Trial

What is Family Office of America Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Family Office of America Valuation Rank Related Terms

Thank you for viewing the detailed overview of Family Office of America's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Family Office of America Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Family Office of America Inc (OTCPK:FOFA) » Definitions » Valuation Rank
Comparable Companies
GTHP SINT NUMD WOK AEMD STME TNON AIMD AMIX ADMT ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
N/A
Address
6898 S. University Boulevard, Suite 100, Centennial, CO, USA, 80122
Website
https://www.qualisinnovations.com
Family Office of America Inc is the holding company of mPathix Health, Inc. The company is focused on the development, production, and distribution of multi-modal pain management and Central Nervous System related solutions. It develops pain management products using a modality-agnostic, virtual operating model. The company is developing a product designed to address the unmet needs of patients who seek alternatives to traditional pain medications and interventions or adjunctive therapies to their current treatment regimen.
Executives
Bin Wang director 112 RICO DR. NORTH, MORGANVILLE NJ 07751